Although studies have suggested that NGR1 and SSB2 may have protective effects in cardiovascular diseases, the precise molecular mechanisms by which these compounds exert their effects on atherosclerosis, either individually or in combination, remain incompletely understood. This evidence concerns the gene RTN4R and atherosclerosis.